Lee Scott Golden - Jun 6, 2023 Form 3 Insider Report for PTC THERAPEUTICS, INC. (PTCT)

Role
Chief Medical Officer
Signature
/s/ Avraham S. Adler, Attorney-in-Fact
Stock symbol
PTCT
Transactions as of
Jun 6, 2023
Transactions value $
$0
Form type
3
Date filed
6/13/2023, 04:26 PM
Next filing
Jan 10, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PTCT Common Stock 39.3K Jun 6, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PTCT Stock Option (Right to Buy) Jun 6, 2023 Common Stock 40.5K $47.06 Direct F2
holding PTCT Stock Option (Right to Buy) Jun 6, 2023 Common Stock 23.1K $66.49 Direct F3
holding PTCT Stock Option (Right to Buy) Jun 6, 2023 Common Stock 10K $38.10 Direct F4
holding PTCT Stock Option (Right to Buy) Jun 6, 2023 Common Stock 13.6K $38.10 Direct F4
holding PTCT Stock Option (Right to Buy) Jun 6, 2023 Common Stock 11.4K $39.42 Direct F5
holding PTCT Stock Option (Right to Buy) Jun 6, 2023 Common Stock 21K $52.85 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes: 1) 713 unvested Restricted Stock Units ("RSUs") from an award of 2,850 RSUs granted on May 11, 2020, which vests in four equal annual installments over four years, commencing on May 11, 2021; 2) 1,980 unvested RSUs from an award of 3,960 RSUs granted on January 6, 2021, which vests in four equal annual installments over four years, commencing on January 6, 2022; 3) 6,117 unvested RSUs from an award of 8,155 RSUs granted on January 7, 2022, which vests in four equal annual installments over four years, commencing on January 7, 2023; 4) 4,500 unvested RSUs from an award of 6,000 RSUs granted on January 7, 2022, which vests in four equal annual installments over four years, commencing on January 7, 2023; 5) 10,640 RSUs granted on January 5, 2023, which vest in four equal annual installments over four years, commencing on January 5, 2024; and 6) 8,400 RSUs granted on April 24, 2023, which vest in four equal annual installments over four years, commencing on April 24, 2024
F2 This option was granted on May 11, 2020, and vests over four years, with 25% of the shares underlying the option vesting on May 11, 2021, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on August 11, 2021.
F3 This option was granted on January 6, 2021, and vests over four years, with 25% of the shares underlying the option vesting on January 6, 2022, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 6, 2022.
F4 This option was granted on January 7, 2022, and vests over four years, with 25% of the shares underlying the option vesting on January 7, 2023, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 7, 2023.
F5 This option was granted on January 5, 2023, and vests over four years, with 25% of the shares underlying the option vesting on January 5, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 5, 2024.
F6 This option was granted on April 24, 2023, and vests over four years, with 25% of the shares underlying the option vesting on April 24, 2024, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on July 24, 2024.